Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,913 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

NCT04693637

Conditions
Adenoviridae Infections, Adenovirus Infection, BK Virus Infection, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Francisco Medical Center San Francisco, California, United States
  • Childrens National Medical Center Northwest Rectangle, District of Columbia, United States
View all 16 locations
View Trial Details
Completed

Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1

NCT04393753

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • UZ Leuven Leuven, Belgium
  • Bordeaux Hôpital Saint Andre Bordeaux, France
  • Hôpital Ambroise Paré - Boulogne-Billancourt Boulogne-Billancourt, France
  • CHU Nantes - Hotel Dieu Nantes, France
View all 22 locations
View Trial Details
Completed

Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC

NCT05253144

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • University Hospital Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • North Bristol NHS Trust Bristol, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • NHS Tayside Dundee, United Kingdom
View all 14 locations
View Trial Details
Completed

Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)

NCT04676724

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Iowa City, Iowa, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site New York, United States
View all 49 locations
View Trial Details

Related conditions